Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer
Gastric cancer is the third leading cause of cancer mortality worldwide. Unfortunately, most gastric cancer cases are diagnosed in an advanced, non-curable stage and with a limited response to chemotherapy. Drug resistance is one of the most important causes of therapy failure in gastric cancer pati...
Main Authors: | Ismael Riquelme, Pablo Letelier, Angela L. Riffo-Campos, Priscilla Brebi, Juan Carlos Roa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/3/424 |
Similar Items
-
Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer
by: Shuli Tang, et al.
Published: (2020-03-01) -
MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
by: Babak Otoukesh, et al.
Published: (2020-06-01) -
MicroRNAs as Diagnostic Biomarkers in Gastric Cancer
by: Jianmin Si, et al.
Published: (2012-10-01) -
The Role and Expression of Angiogenesis-Related miRNAs in Gastric Cancer
by: Martina Giuppi, et al.
Published: (2021-02-01) -
Viruses and miRNAs: More Friends than Foes
by: Patrice Bruscella, et al.
Published: (2017-05-01)